The NOD2 agonist muramyl-di-peptide (MDP) reverses the inhibitory effects of TLR4 activation on enterocyte proliferation through effects on beta-catenin signaling, and attenuates the severity of experimental necrotizing enterocolitis

✍ Scribed by Ward M. Richardson; Xiao-Hua Shi; Steven C. Gribar; Maria Branca; Theresa Dubowski; Jun Li; Chhindler Sodhi; David J. Hackam

• Book ID: 113678625
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 49 KB
• Volume: 207
• Category: Article
• ISSN: 1072-7515
• DOI: 10.1016/j.jamcollsurg.2008.06.064